HK1177229A1 - Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma - Google Patents
Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinomaInfo
- Publication number
- HK1177229A1 HK1177229A1 HK13104815.0A HK13104815A HK1177229A1 HK 1177229 A1 HK1177229 A1 HK 1177229A1 HK 13104815 A HK13104815 A HK 13104815A HK 1177229 A1 HK1177229 A1 HK 1177229A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diagnosis
- new method
- hepatocellular carcinoma
- marker consisting
- plasma microrna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2011/073774 WO2012151736A1 (en) | 2011-05-06 | 2011-05-06 | Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1177229A1 true HK1177229A1 (en) | 2013-08-30 |
Family
ID=47138644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13104815.0A HK1177229A1 (en) | 2011-05-06 | 2013-04-22 | Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma |
Country Status (6)
Country | Link |
---|---|
US (1) | US20130237456A1 (xx) |
EP (1) | EP2596136B1 (xx) |
JP (1) | JP5753905B2 (xx) |
KR (1) | KR101532210B1 (xx) |
HK (1) | HK1177229A1 (xx) |
WO (1) | WO2012151736A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112016029634A2 (pt) | 2014-06-18 | 2017-10-24 | Nat Cancer Ct | kit, dispositivo e método para a detecção de câncer de fígado |
WO2016097370A2 (en) | 2014-12-18 | 2016-06-23 | Bergen Teknologioverføring As | Anti-axl antagonistic antibodies |
DK3814533T3 (da) | 2018-09-20 | 2021-11-15 | Tamirna Gmbh | Mikro-RNA-signaturer til forudsigelse af leverdysfunktion |
JP7058612B2 (ja) | 2019-01-10 | 2022-04-22 | 株式会社丸山製作所 | 防振装置を備えた動力作業機及び背負式動力作業機 |
CN111235271A (zh) * | 2019-12-12 | 2020-06-05 | 中山大学附属第三医院 | 基于指导肝细胞癌的精准治疗中的应用及用于试剂盒 |
CN113186224B (zh) * | 2021-04-29 | 2023-01-10 | 中国人民解放军陆军军医大学士官学校 | 具有抑制乙肝病毒复制活性的microRNA-27a及其应用 |
CN113755597B (zh) * | 2021-10-14 | 2022-12-06 | 杭州师范大学 | 外周血外泌体miRNA联合标志物在制备检测HBV阳性肝硬化早期肝癌试剂盒中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE180489T1 (de) * | 1989-12-19 | 1999-06-15 | Us Health | Für leberzellkarzinom spezifisches onkogen |
AU2007314212B2 (en) * | 2006-11-01 | 2014-05-29 | The Govt. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services | MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma |
ES2575868T3 (es) * | 2007-09-14 | 2016-07-01 | The Ohio State University Research Foundation | Expresión de miARN en microvesículas de sangre periférica humana y sus usos |
JP5116026B2 (ja) * | 2008-01-23 | 2013-01-09 | 富士フイルム株式会社 | 癌の検出方法および癌抑制剤 |
CN101368213A (zh) * | 2008-10-13 | 2009-02-18 | 南京大学 | 血清微小核糖核酸试剂盒及其在乙肝早期诊断中的应用 |
CN102985558B (zh) * | 2008-11-13 | 2015-08-19 | 复旦大学 | 用于肝细胞癌症的微rna表达谱分析的组合物和方法 |
ITMI20091538A1 (it) * | 2009-09-07 | 2011-03-08 | Istituto Naz Di Genetica Mole Colare Ingm | Profili di espressione di micro-rna nel sangue periferico di pazienti affetti da epatocarcinoma o cirrosi epatica e loro usi |
CN102021169A (zh) * | 2010-10-14 | 2011-04-20 | 南京大学 | 一种血清/血浆miRNA组合物及其应用 |
-
2011
- 2011-05-06 EP EP11865138.9A patent/EP2596136B1/en not_active Not-in-force
- 2011-05-06 WO PCT/CN2011/073774 patent/WO2012151736A1/en active Application Filing
- 2011-05-06 US US13/808,129 patent/US20130237456A1/en not_active Abandoned
- 2011-05-06 KR KR1020127029798A patent/KR101532210B1/ko active IP Right Grant
- 2011-05-06 JP JP2013532030A patent/JP5753905B2/ja active Active
-
2013
- 2013-04-22 HK HK13104815.0A patent/HK1177229A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20130237456A1 (en) | 2013-09-12 |
KR101532210B1 (ko) | 2015-06-29 |
JP5753905B2 (ja) | 2015-07-22 |
JP2013538583A (ja) | 2013-10-17 |
EP2596136B1 (en) | 2014-07-16 |
EP2596136A1 (en) | 2013-05-29 |
EP2596136A4 (en) | 2013-12-25 |
KR20130029079A (ko) | 2013-03-21 |
WO2012151736A1 (en) | 2012-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212926A1 (zh) | 治療肝細胞癌的方法 | |
HK1198547A1 (en) | Methods for detection of nucleotide modification | |
ZA201305150B (en) | Processes for preparing isoquinolinones and solid forms of isoquinolinones | |
EP2691121A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE | |
EP2773754A4 (en) | Methods of Treatment | |
EP2700719A4 (en) | METHOD AND PRIMER FOR DETECTING MI-RNA AND APPLYING THEREOF | |
GB201110095D0 (en) | Method of treatment | |
GB2503842B (en) | Composition and method of manufacture | |
HK1177229A1 (en) | Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma | |
ZA201403302B (en) | Method for inhibition of deubiquitinating acttivity | |
PL2607482T3 (pl) | Roztwór do ekstrakcji RNA | |
EP2745256A4 (en) | APPARATUS AND METHOD FOR DETERMINING MEDICATION LOCATION | |
IL227992A0 (en) | Compositions and methods for extractive filtration of microorganisms | |
IL232424A0 (en) | Process for the preparation of 1-acyl-4-phenylsulfonylprolinamide derivatives and intermediates | |
IL231505A0 (en) | Pharmaceutical preparation and method for its production | |
AP2013007019A0 (en) | Gaming system and method of use | |
GB201223160D0 (en) | Preparation method of AL-ZR-C master alloy | |
EP2791324A4 (en) | PROCESSING METHOD | |
GB201107118D0 (en) | Method of diagnosis and prognosis | |
GB201102475D0 (en) | Method of reducing offset | |
EP2707569A4 (en) | DORN ARRANGEMENT AND OPERATING PROCEDURE THEREFOR | |
GB201102364D0 (en) | Lock means and method of use thereof | |
GB201111530D0 (en) | Method of treatment | |
GB201109509D0 (en) | Method of treatment | |
GB201109266D0 (en) | Method of treatment |